Mirum Pharmaceuticals (MIRM) Other Non Operating Income (2019 - 2025)

Mirum Pharmaceuticals' Other Non Operating Income history runs 7 years deep, the most recent figure standing at -$218000.0 for Q4 2025.

• In Q4 2025, Other Non Operating Income rose 77.8% year-over-year to -$218000.0; the TTM figure through Mar 2026 stood at $263000.0 (down 25.07% YoY), while the FY2025 annual figure was $2.4 million, changed N/A from the prior year.
• Other Non Operating Income was -$218000.0 for Q4 2025 at Mirum Pharmaceuticals, down from $395000.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $2.1 million in Q1 2025 to a low of -$49.1 million in Q2 2023.
• Historically, Other Non Operating Income has averaged -$2.4 million across 5 years, with a median of -$26000.0 in 2021.
• The sharpest annual moves came in 2022 and 2023: Other Non Operating Income soared 2247.06% in 2022, then tumbled 3877.98% in 2023.
• A 5-year view of Other Non Operating Income shows it stood at -$17000.0 in 2021, then jumped by 2247.06% to $365000.0 in 2022, then sank by 938.63% to -$3.1 million in 2023, then soared by 67.92% to -$982000.0 in 2024, then surged by 77.8% to -$218000.0 in 2025.
• The last three Other Non Operating Income figures came in at -$218000.0 (Q4 2025), $395000.0 (Q3 2025), and $86000.0 (Q2 2025), per Business Quant data.